Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea
In: Blood Cancer Journal, Jg. 8 (2018), Heft 6, S. 1-3
Online
unknown
Zugriff:
Titel: |
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea
|
---|---|
Autor/in / Beteiligte Person: | Gambacorti-Passerini, Carlo ; Aroldi, Andrea ; Renso, Rossella ; Elena Maria Elli ; Pioltelli, Pietro ; Renso, R ; Aroldi, A ; Pioltelli, P ; Gambacorti-Passerini, C ; Elli, E |
Link: | |
Zeitschrift: | Blood Cancer Journal, Jg. 8 (2018), Heft 6, S. 1-3 |
Veröffentlichung: | Nature Publishing Group, 2018 |
Medientyp: | unknown |
ISSN: | 2044-5385 (print) |
Schlagwort: |
|
Sonstiges: |
|